ES2168326T3 - Acidos imidobisfosforicos, procedimiento para su preparacion y su uso. - Google Patents
Acidos imidobisfosforicos, procedimiento para su preparacion y su uso.Info
- Publication number
- ES2168326T3 ES2168326T3 ES95115276T ES95115276T ES2168326T3 ES 2168326 T3 ES2168326 T3 ES 2168326T3 ES 95115276 T ES95115276 T ES 95115276T ES 95115276 T ES95115276 T ES 95115276T ES 2168326 T3 ES2168326 T3 ES 2168326T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- opt
- substd
- imidobisphosphoric
- nhcor7
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 150000007513 acids Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 5
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/222—Amides of phosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/664—Amides of phosphorus acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/22—Amides of acids of phosphorus
- C07F9/24—Esteramides
- C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
- C07F9/2479—Compounds containing the structure P(=X)n-N-acyl, P(=X)n-N-heteroatom, P(=X)n-N-CN (X = O, S, Se; n = 0, 1)
- C07F9/2495—Compounds containing the structure P(=X)n-N-acyl, P(=X)n-N-heteroatom, P(=X)n-N-CN (X = O, S, Se; n = 0, 1) containing the structure P(=X)n-N-P (X = O, S, Se; n = 0, 1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glass Compositions (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Saccharide Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Fuel Cell (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dental Preparations (AREA)
Abstract
SE DESCRIBEN COMPUESTOS DE LA FORMULA I DONDE R 1 SIGNIFICA (C{SUB, 1} - C{SUB, 10}) - ALQUILO, (C{SUB, 1} - C{SUB, 8} - ALCANOILO, (C{SUB, 6} - C{SUB, 10}) ARILO O HET, QUE PUEDEN SER SUSTITUIDOS POR HALOGENO, - OH, NH{SUB, 2}, - NH - CO - R{SUP, 7}, - O - CO - R{SUP, 7} Y - N (R{SUP, 8}){SUB, 2}, CON R{SUP, 7} = (C{SUB, 1} - C{SUB, 6} ALQUILO Y R{SUP, 8} DE FORMA INDEPENDIENTE UNO DE OTRO SON HIDROGENO O (C{SUB, 1} - C{SUB, 3}) - ALQUILO O DONDE R{SUP, 1} ES UN RESTO DE LA FORMULA II DONDE N ES UNA CIFRA COMPLETA DESDE 3 HASTA 10, M ES CERO HASTA 3, R{SUP, 6} DE FORMA INDEPENDIENTE UNO DE OTRO SON (C{SUB, 1} C{SUB, 6}) - ALQUILO, QUE ES SUSTITUIDO POR HALOGENO O - NH CO - R{SUP, 7}, CON R{SUP, 7} = (C{SUB, 1 - C{SUB, 6}) ALQUILO, Y X ESTA AUSENTE O SIGNIFICA (C{SUB, 1} - C{SUB, 10}) - ALQUILO, Y R{SUB, 2}, R{SUB, 3}, R{SUB, 4} O R{SUP, 5} DE FORMA INDEPENDIENTE UNO DE OTRO SON HIDROGENO (C{SUB, 1} - C{SUB, 5}) ALQUILO, LITIO, SODIO, POTASIO O SI(R), CON R = (C{SUB, 1} C{SUB, 5} - ALQUILO,ASI COMO SUS SALES TOLERABLES FISIOLOGICAMENTE, UN PROCESO PARA LA ELABORACION DE ESTOS COMPUESTOS DE LA FORMULA I ASI COMO SU UTILIZACION PARA MEDICAMENTO EN LA PROFILAXIS Y TRATAMIENTO DE OSTEOPOROSIS E HIPERCALCEMIA.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4435496A DE4435496A1 (de) | 1994-10-04 | 1994-10-04 | Imidobisphosphorsäuren, Verfahren zu ihrer Herstellung und Verwendung derselben |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2168326T3 true ES2168326T3 (es) | 2002-06-16 |
Family
ID=6529953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES95115276T Expired - Lifetime ES2168326T3 (es) | 1994-10-04 | 1995-09-28 | Acidos imidobisfosforicos, procedimiento para su preparacion y su uso. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5733897A (es) |
| EP (1) | EP0705839B1 (es) |
| JP (1) | JP3927252B2 (es) |
| KR (1) | KR960014146A (es) |
| AT (1) | ATE210137T1 (es) |
| AU (1) | AU703109B2 (es) |
| CA (1) | CA2159776C (es) |
| DE (2) | DE4435496A1 (es) |
| DK (1) | DK0705839T3 (es) |
| ES (1) | ES2168326T3 (es) |
| FI (1) | FI954684A (es) |
| HU (1) | HUT73660A (es) |
| IL (1) | IL115480A0 (es) |
| NO (1) | NO307258B1 (es) |
| NZ (1) | NZ280149A (es) |
| PT (1) | PT705839E (es) |
| ZA (1) | ZA958292B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040181078A1 (en) * | 1997-10-10 | 2004-09-16 | Pharmasset, Ltd. | Tetraphosphonate bicyclic trisanhydrides |
| KR101761830B1 (ko) | 2015-10-21 | 2017-07-26 | 주식회사 엘지화학 | 리간드 화합물, 올레핀 올리고머화용 촉매계, 및 이를 이용한 올레핀 올리고머화 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2798086A (en) * | 1956-02-14 | 1957-07-02 | Eastman Kodak Co | Amides and esters of iminodiphosphoric acid and nitrilotriphosphoric acid |
| DE1041044B (de) * | 1957-07-05 | 1958-10-16 | Benckiser Gmbh Joh A | Verfahren zur Herstellung von N-substituierten Derivaten der Imidodiphosphorsaeure |
| FI89366C (fi) * | 1990-12-20 | 1993-09-27 | Leiras Oy | Foerfarande foer framstaellning av nya farmakologiskt anvaendbara metylenbisfosfonsyraderivat |
| JPH06298779A (ja) * | 1993-04-15 | 1994-10-25 | Hoechst Japan Ltd | ヘテロ環イミノビスメチレンビスホスホン酸誘導体 |
-
1994
- 1994-10-04 DE DE4435496A patent/DE4435496A1/de not_active Withdrawn
-
1995
- 1995-09-08 US US08/525,104 patent/US5733897A/en not_active Expired - Lifetime
- 1995-09-28 AT AT95115276T patent/ATE210137T1/de not_active IP Right Cessation
- 1995-09-28 DK DK95115276T patent/DK0705839T3/da active
- 1995-09-28 EP EP95115276A patent/EP0705839B1/de not_active Expired - Lifetime
- 1995-09-28 PT PT95115276T patent/PT705839E/pt unknown
- 1995-09-28 DE DE59509904T patent/DE59509904D1/de not_active Expired - Lifetime
- 1995-09-28 ES ES95115276T patent/ES2168326T3/es not_active Expired - Lifetime
- 1995-10-02 FI FI954684A patent/FI954684A/fi unknown
- 1995-10-02 NZ NZ280149A patent/NZ280149A/en unknown
- 1995-10-02 IL IL11548095A patent/IL115480A0/xx unknown
- 1995-10-02 AU AU33006/95A patent/AU703109B2/en not_active Ceased
- 1995-10-03 JP JP25607595A patent/JP3927252B2/ja not_active Expired - Fee Related
- 1995-10-03 CA CA002159776A patent/CA2159776C/en not_active Expired - Fee Related
- 1995-10-03 NO NO953929A patent/NO307258B1/no not_active IP Right Cessation
- 1995-10-03 ZA ZA958292A patent/ZA958292B/xx unknown
- 1995-10-04 KR KR1019950033776A patent/KR960014146A/ko active IP Right Grant
- 1995-10-04 HU HU9502901A patent/HUT73660A/hu unknown
-
1997
- 1997-12-12 US US08/989,797 patent/US5935947A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FI954684A (fi) | 1996-04-05 |
| HU9502901D0 (en) | 1995-11-28 |
| US5935947A (en) | 1999-08-10 |
| NZ280149A (en) | 1997-05-26 |
| NO953929L (no) | 1996-04-09 |
| DE59509904D1 (de) | 2002-01-17 |
| NO953929D0 (no) | 1995-10-03 |
| AU703109B2 (en) | 1999-03-18 |
| FI954684A0 (fi) | 1995-10-02 |
| HUT73660A (en) | 1996-09-30 |
| PT705839E (pt) | 2002-05-31 |
| EP0705839A1 (de) | 1996-04-10 |
| DK0705839T3 (da) | 2002-04-02 |
| CA2159776A1 (en) | 1996-04-05 |
| EP0705839B1 (de) | 2001-12-05 |
| ZA958292B (en) | 1996-04-24 |
| NO307258B1 (no) | 2000-03-06 |
| CA2159776C (en) | 2007-04-24 |
| US5733897A (en) | 1998-03-31 |
| ATE210137T1 (de) | 2001-12-15 |
| DE4435496A1 (de) | 1996-04-11 |
| IL115480A0 (en) | 1996-01-19 |
| JP3927252B2 (ja) | 2007-06-06 |
| AU3300695A (en) | 1996-04-18 |
| KR960014146A (ko) | 1996-05-22 |
| JPH08119981A (ja) | 1996-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO305365B1 (no) | Cykloalkano-indol- og -azaindolderivater, ogsÕ for terapeutisk anvendelse, legemidler inneholdende slike derivater, anvendelse av forbindelsene og deres derivater for fremstilling av legemidler samt mellomprodukter | |
| NO941696D0 (no) | HIV-proteaseinhibitorer som er anvendbare for behandling av AIDS | |
| NO304264B1 (no) | Fenylsubstituerte alkenylkarboksylsyreguanidider som bµrer perfluoralkenylgrupper, deres anvendelse for fremstilling av medikament eller diagnostikum samt medikament inneholdende forbindelsen | |
| DE3682032D1 (de) | Propylamine, verfahren zu ihrer herstellung und ihre verwendung als fungizide. | |
| ES2168326T3 (es) | Acidos imidobisfosforicos, procedimiento para su preparacion y su uso. | |
| GR3021512T3 (en) | Pyridazinediones and their use in the treatment of neurological disorders | |
| DK471686D0 (da) | Tetrahydro-beta-carboliner, fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel | |
| IL119054A0 (en) | Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them | |
| ES8602770A1 (es) | "procedimiento para la produccion de compuestos de bis-qui- nazolina" | |
| SE8103258L (sv) | Nya kinoxalin-1,4-derivat med den allmenna formeln | |
| ZA849277B (en) | Use of 3-amino-1,2-benzisothiazoles as microbicides for protecting industrial materials | |
| PH24016A (en) | 3-piperidinyl-substituted 1,2-benzosoxazoles and 1,2-benzisothiazoles | |
| FR2021123A1 (fr) | Nouveaux derives du 1,3-diamino-propane-2-ol | |
| IT1217657B (it) | Composti con attivita' analgesica centrale | |
| HUP9903423A3 (en) | 3-descladinose-2,3-anhydroerythromycin derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 705839 Country of ref document: ES |